Conference Speakers

Hiromi Sakai received Ph.D. (D.Eng.) in polymer chemistry in 1994 from Waseda Univ., Tokyo, with a thesis entitled “Hemoglobin-vesicles (HbV) as a molecular assembly” (Supervisor, late Prof. E. Tsuchida). In 1996-1998 he studied at Dept. Bioengineering, UC San Diego (Supervisor, Prof. M. Intaglietta) and evaluated the microvascular responses to HbV injection. After coming back to Tokyo, he studied stabilization and biocompatibility of HbV and evaluated in vivo safety and efficacy. In 2006 he received Ph.D. (D.Med.Sci.) from Keio Univ. School of Medicine (Supervisor, Prof. K. Kobayashi). Dr. Sakai was a Lecturer and an Associate Professor at Research Institute for Sci.&Eng. Waseda Univ. in 1998-2009, and PI at Waseda Bioscience Research Institute in Singapore in 2009-2013. From 2013 he has been the Professor of Chemistry, Nara Medical University. He is the chief investigator of the artificial red cells project, which has been supported by the Japan Agency for Medical Research and Development: AMED since 2015. From 2019 he is the fourth president of the Society of blood Substitutes, Japan. He was the co-president of the 17th-ISBS-2019 held in Nara, Japan.